GSK to tie up with Vir over COVID-19 treatments

Note: This section contains information in English only.
Source: Dukascopy Bank SA
The UK drugmaker GlaxoSmithKline is planning to make a $250M investment in Vir Biotechnology and cooperate over the development of treatments for the COVID-19 disease, both companies stated on Monday.
Back to articles

Actual Topics

Mon, 06 Apr 2020 13:40:02 GMT

UK committed to continuing negotiations with EU

Britain is committed to continuing talks with the EU bloc on their relationship in the future, Prime Minister Boris Johnson's spokesman said on Monday.

Mon, 06 Apr 2020 11:36:44 GMT

Norwegian Air's traffic drops 60% in March

Norwegian Air's passenger capacity plunged by 60% year-over-year last month as the airline was forced to ground its planes due to the coronavirus outbreak and efforts to stop spreading the virus.

Subscribe to "Fundamental Analysis" feed

Subscribe
Per scoprire di più sulla piattaforma di Dukascopy Bank per Forex/CFD, sul SWFX ed altre informazioni relative al trading,
la preghiamo di contattarci o richiedere di essere contattato (callback request)
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
Per scoprire di più sulla piattaforma di Dukascopy Bank per Forex/CFD, sul SWFX ed altre informazioni relative al trading,
la preghiamo di contattarci o richiedere di essere contattato (callback request).
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.